查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370966

呼吸道疾病测试市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按测试类型、按应用、最终用户、地区和竞争细分

Respiratory Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年，全球呼吸道疾病检测市场估值达到 60.1 亿美元，预计在整个预测期内强劲扩张，预计复合年增长率 (CAGR) 为 5.72%，到 2028 年预计将达到 83.0 亿美元。包括肺功能和相关过程的评估，统称为呼吸诊断。这涉及一系列机械、影像和分子诊断测试，旨在检测气喘、慢性阻塞性肺病 (COPD)、肺癌、支气管炎和肺纤维化等疾病。此领域应用的技术包括肺活量测定法、血氧测定法、经皮二氧化碳监测、鼻吸气压 (SNIP)、胸部 X 光检查和电脑断层扫描 (CT) 扫描。在特定情况下，还可以进行睡眠研究来诊断睡眠呼吸中止症和夜间通气不足。

主要市场驱动因素：

呼吸系统疾病的负担日益加重：呼吸系统疾病盛行率的上升是市场成长的关键驱动力。吸烟、饮酒、久坐的生活方式和压力等因素增加了慢性阻塞性肺病和肺癌等其他严重呼吸道疾病的病例数。此外，呼吸诊断测试技术的进步，包括用于慢性阻塞性肺病诊断和门诊管理的物联网（IoT）和人工智慧（AI），对市场扩张产生了积极影响。私立医院和医疗中心对呼吸诊断设备的需求不断增长。政府和非政府组织 (NGO) 也在努力提高获得优质医疗保健的机会，促进市场成长。呼吸道症状是到基层医疗中心就诊的主要原因之一，凸显了呼吸道疾病负担日益增加及其对呼吸道疾病检测需求的影响。

市场概况
预测期 2024-2028
2022 年市场规模 60.1亿美元
2028 年市场规模 83亿美元
2023-2028 年复合年增长率 5.72%
成长最快的细分市场 肺癌
最大的市场 北美洲

测试设备和模式的技术进步：市场正在见证技术进步的巨大牵引力。该领域的主要参与者专注于人工智慧 (AI) 和机器学习技术的开发，以优化治疗方案并提高患者治疗效果。例如，Respira Labs 推出了一款名为 Sylvee 的人工智慧可穿戴设备，用于监测肺功能，从而实现慢性阻塞性肺病的早期诊断和管理。收购也促进了市场成长，CAIRE Inc. 收购 MGC Diagnostics Holdings 以实现产品多元化并巩固其市场地位就体现了这一点。

老年人口不断增加：全球老年人口预计将激增，随之而来的是由于呼吸系统的生理变化而导致的呼吸道感染的易感性。由于老年人的呼吸系统疾病更为严重，早期发现并了解这些疾病对于改善患者的治疗效果至关重要。因此，老年人口的增加推动了呼吸道疾病检测市场的成长。

主要市场挑战：

高成本和缺乏熟练的专业人员：诊断程序成本高昂，技术的快速进步导致合格专家的短缺。这种短缺阻碍了程序的正确执行，包括仪器的处理和测试的执行，从而阻碍了市场的成长。

有限的报销政策：全球范围内报销政策不足或不存在可能会阻碍诊断测试的需求，从而限制市场成长。如果没有适当的报销，患者可能会犹豫是否接受呼吸系统疾病检测，从而导致诊断和治疗的延迟，特别是在亚太地区。

主要市场趋势：

床边检测 (POCT) 扩展：呼吸系统疾病床边检测的扩展有助于在各种医疗机构中进行快速、方便的检测。 POCT 设备可快速提供结果，有助于及时诊断和监测，特别是在资源有限的环境中。

人工智慧 (AI) 的整合：人工智慧驱动的演算法提高了呼吸系统疾病测试结果的准确性和解释，从而实现更精确的诊断和个人化的治疗建议。人工智慧可以识别人类专家可能会错过的模式和相关性，从而彻底改变呼吸系统疾病的诊断。

细分洞见：

测试类型洞察：市场分为影像测试、机械测试和体外诊断测试。体外诊断测试因其广泛采用和功效而占据主导地位。由于对精确诊断方法的需求增加和成像技术的进步，成像测试正在快速成长。

最终用户见解：医院凭藉全面的护理和多学科方法占据市场主导地位。在门诊护理趋势不断增长和对独立诊断服务的需求的推动下，诊断中心正在迅速发展。

区域洞察：由于先进的医疗基础设施、医疗支出和呼吸道疾病的流行，北美保持主导地位。亚太地区是成长最快的地区，其推动因素包括庞大的人口基数、城市化进程、对呼吸道疾病的认识以及医疗基础设施的改善。

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球呼吸系统疾病检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依测试类型（成像测试、机械测试和体外诊断测试）
    • 按应用（慢性阻塞性肺病、肺癌、气喘、结核病）
    • 按最终使用者（医院、诊断中心等）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美呼吸道疾病检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲呼吸道疾病检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按应用
    • 按最终用户
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太呼吸系统疾病检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按应用
    • 按最终用户
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲呼吸道疾病检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按应用
    • 按最终用户
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲呼吸道疾病检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按应用
    • 按最终用户
  • MEA：国家分析
    • 南非呼吸道疾病检测
    • 沙乌地阿拉伯呼吸道疾病检测
    • 阿联酋呼吸道疾病检测

第 11 章：市场动态

第 12 章：市场趋势与发展

第 13 章：全球呼吸系统疾病检测市场：SWOT 分析

第14章：竞争格局

  • 商业概览
  • 服务产品
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Beckton Dickinson and Company
    • Koninklijke Philips NV
    • ResMed Inc.
    • Medtronic PLC
    • Carestream Health
    • MG Diagnostic Corporation
    • Abbott Laboratories
    • ThermoFisher Scientific
    • Biomerieux
    • QIAGEN

第 15 章：策略建议

第 16 章：关于我们与免责声明

简介目录
Product Code: 4698

The Global Respiratory Disease Testing Market achieved a valuation of USD 6.01 Billion in 2022 and is poised for robust expansion throughout the forecast period with a projected Compound Annual Growth Rate (CAGR) of 5.72% and expected to reach USD 8.30 Billion through 2028. This market encompasses the evaluation of lung function and associated processes, collectively known as respiratory diagnostics. This involves a spectrum of mechanical, imaging, and molecular diagnostic tests aimed at detecting conditions such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. The techniques applied in this domain include spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray, and computed tomography (CT) scan. In specific cases, sleep studies may also be conducted to diagnose sleep apnea and nocturnal hypoventilation.

Key Market Drivers:

Growing Burden of Respiratory Diseases: The rising prevalence of respiratory diseases acts as a pivotal driver for market growth. Factors such as increased smoking, alcohol consumption, sedentary lifestyles, and stress have contributed to the escalation of COPD cases and other severe respiratory conditions like lung cancer. Moreover, advancements in respiratory diagnostic testing technologies, including Internet of Things (IoT) and Artificial Intelligence (AI) for COPD diagnosis and outpatient management, have positively influenced market expansion. Private hospitals and healthcare centers exhibit escalating demand for respiratory diagnostic devices. Government and non-governmental organizations (NGOs) are also striving to enhance access to quality healthcare, fostering market growth. Respiratory symptoms are among the primary reasons for seeking medical consultation in primary healthcare centers, underscoring the growing burden of respiratory diseases and their impact on the demand for respiratory disease testing.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 6.01 Billion
Market Size 2028USD 8.30 Billion
CAGR 2023-20285.72%
Fastest Growing SegmentLung Cancer
Largest MarketNorth America

Technological Advancements in Testing Devices and Modalities: The market is witnessing significant traction from technological advancements. Key players in this arena are focusing on the development of Artificial Intelligence (AI) and machine learning technologies to optimize treatment protocols and enhance patient outcomes. For example, Respira Labs introduced an AI-powered wearable device named Sylvee for monitoring lung function, enabling early COPD diagnosis and management. Acquisitions are also contributing to market growth, as seen through CAIRE Inc.'s acquisition of MGC Diagnostics Holdings to diversify their offerings and consolidate their position in the market.

Increasing Geriatric Population: The global geriatric population is projected to surge, and with it, the susceptibility to respiratory infections due to physiological changes in the respiratory system. As respiratory diseases are more severe in the elderly, early detection and understanding of these conditions are crucial for improving patient outcomes. The rising elderly population thus fuels the growth of the respiratory disease testing market.

Increasing Government Initiatives: Government initiatives are pivotal in fostering advancements and growth in the respiratory disease testing market. National action plans focused on respiratory diseases, surveillance programs, research funding, and public awareness campaigns create an environment conducive to research, innovation, and improved healthcare infrastructure. These initiatives play a vital role in addressing the global burden of respiratory diseases and enhancing patient outcomes.

Key Market Challenges:

High Cost and Lack of Skilled Professionals: Diagnostic procedures come with a substantial cost, and the rapid advancement of technology has led to a shortage of qualified specialists. This shortage hampers the proper execution of procedures, including the handling of instruments and execution of tests, thereby impeding market growth.

Limited Reimbursement Policies: Inadequate or nonexistent reimbursement policies globally can hinder the demand for diagnostic tests, limiting market growth. Without proper reimbursement, patients may hesitate to undergo respiratory disease testing, leading to delayed diagnosis and treatment, particularly in the Asia Pacific region.

Key Market Trends:

Point-of-Care Testing (POCT) Expansion: The expansion of point-of-care testing for respiratory diseases facilitates rapid and convenient testing in various healthcare settings. POCT devices provide quick results, aiding timely diagnosis and monitoring, particularly in resource-limited environments.

Integration of Artificial Intelligence (AI): AI-driven algorithms enhance the accuracy and interpretation of respiratory disease test results, leading to more precise diagnoses and personalized treatment recommendations. AI can identify patterns and correlations that human experts might miss, revolutionizing respiratory disease diagnostics.

Segmental Insights:

Test Type Insights: The market is categorized into Imaging Tests, Mechanical Tests, and In-vitro Diagnostic Tests. In-vitro Diagnostic Tests are dominant due to their broad adoption and efficacy. Imaging Tests are experiencing rapid growth due to increased demand for precise diagnostic methods and advancements in imaging technology.

End User Insights: Hospitals dominate the market due to their comprehensive care and multidisciplinary approach. Diagnostic centers are growing rapidly, fueled by the increasing trend towards outpatient care and demand for standalone diagnostic services.

Regional Insights: North America maintains dominance due to advanced healthcare infrastructure, healthcare expenditure, and prevalence of respiratory diseases. Asia Pacific is the fastest growing region, driven by a large population base, urbanization, awareness about respiratory diseases, and improving healthcare infrastructure.

Key Market Players

  • Beckton Dickinson and Company
  • Koninklijke Philips N.V.
  • ResMed Inc.
  • Medtronic PLC
  • Carestream Health
  • MG Diagnostic Corporation
  • Abbott Laboratories
  • ThermoFisher Scientific
  • Biomerieux
  • QIAGEN

Report Scope:

In this report, the Global Respiratory Disease Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Respiratory Disease Testing Market, By Test Type:

  • Imaging Tests
  • Mechanical Tests
  • In-vitro Diagnostic Tests

Respiratory Disease Testing Market, By Application:

  • COPD
  • Lung Cancer
  • Asthma
  • Tuberculosis

Respiratory Disease Testing Market, By End User:

  • Hospitals
  • Diagnostic Centres
  • Others

Respiratory Disease Testing Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Disease Testing Market.

Available Customizations:

  • Global Respiratory Disease Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Respiratory Disease Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Imaging Tests, Mechanical Tests, and In-vitro Diagnostic Tests)
    • 5.2.2. By Application (COPD, Lung Cancer, Asthma, Tuberculosis)
    • 5.2.3. By End User (Hospitals, Diagnostic Centres, and Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Respiratory Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Respiratory Disease Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Respiratory Disease Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Respiratory Disease Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Respiratory Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Application
    • 7.2.3. By End User
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Respiratory Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Respiratory Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Respiratory Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Respiratory Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Respiratory Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Respiratory Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Application
    • 8.2.3. By End User
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Respiratory Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Respiratory Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Respiratory Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Respiratory Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Respiratory Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Respiratory Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Application
    • 9.2.3. By End User
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Respiratory Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Respiratory Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Respiratory Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Respiratory Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Application
    • 10.2.3. By End User
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Respiratory Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Respiratory Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Respiratory Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

12. Market Trends & Developments

13. Global Respiratory Disease Testing Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Services Offerings
  • 14.3. Recent Developments
  • 14.4. Key Personnel
  • 14.5. SWOT Analysis
    • 14.5.1. Beckton Dickinson and Company
    • 14.5.2. Koninklijke Philips N.V.
    • 14.5.3. ResMed Inc.
    • 14.5.4. Medtronic PLC
    • 14.5.5. Carestream Health
    • 14.5.6. MG Diagnostic Corporation
    • 14.5.7. Abbott Laboratories
    • 14.5.8. ThermoFisher Scientific
    • 14.5.9. Biomerieux
    • 14.5.10. QIAGEN

15. Strategic Recommendations

16. About Us & Disclaimer